France is set to radically overhaul its drug regulatory systemBMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4979 (Published 03 August 2011) Cite this as: BMJ 2011;343:d4979
- Sophie Arie
France’s health minister, Xavier Bertrand, has presented a bill to overhaul the country’s drug regulatory system in the wake of the scandal over the continued use of the antidiabetes drug benfluorex in France, long after it was banned in other countries.
The bill aims to crack down on conflicts of interest, restructure the country’s drug regulator, and tighten the process for licensing drugs and for monitoring their effects once in use.
“We will know everything, everything,” the minister told the French media this week, comparing the bill to the US “Sunshine Act” introduced in 1976 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial